Jie Zhang,Drago Robert Sliskovic,Charles E. Ducker
申请号：
US13318151
公开号：
US20120046357A1
申请日:
2010.04.29
申请国别(地区):
US
年份:
2012
代理人:
摘要：
The invention relates to compounds of formula (1) and formula (2),and pharmaceutically acceptable salts thereof for the treatment of cancer, inflammation, auto-immune diseases, diabetes and diabetic complications, infection, cardiovascular disease and ischemia-reperfusion injuries, wherein R1 is defined herein.
